Medtecs Intl 546

SGD 0.106 +0.00% +0.00 Updated 29 Oct 2026, 13:22 SGT

Financials

Medtecs International Corporation Limited Annual Report 2025

Open annual report

Explore the statements

14 tables

Group Comprehensive Income

21 metrics

Units appear below each metric. Scroll to compare years

Group Comprehensive Income from Medtecs International Corporation Limited Annual Report 2025
Metric / unit 2025Group2024Group Source
Group Comprehensive Income
RevenueUSD thousand 78,96654,423 PDF p. 76
Costs of sales and servicesUSD thousand (66,320)(47,541) PDF p. 76
Gross profitUSD thousand 12,6466,882 PDF p. 76
Other income netUSD thousand 1,4394,371 PDF p. 76
Financial incomeUSD thousand 9151,457 PDF p. 76
Distribution and selling expensesUSD thousand (6,041)(5,898) PDF p. 76
Administrative expensesUSD thousand (10,222)(17,384) PDF p. 76
Allowance for expected credit losses on receivablesUSD thousand (3,070)(12,074) PDF p. 76
Financial expensesUSD thousand (811)(794) PDF p. 76
Loss before taxUSD thousand (5,144)(23,440) PDF p. 76
Tax credit or expenseUSD thousand 384(509) PDF p. 76
Net loss for the yearUSD thousand (4,760)(23,949) PDF p. 76
Foreign currency translation reserveUSD thousand 252(659) PDF p. 76
Remeasurement loss or gain on retirement benefit obligation net of taxUSD thousand (96)46 PDF p. 76
Total comprehensive lossUSD thousand (4,604)(24,562) PDF p. 76
Net loss attributable to equity holdersUSD thousand (4,765)(22,422) PDF p. 76
Net profit or loss attributable to non-controlling interestsUSD thousand 5(1,527) PDF p. 76
Total net loss attributableUSD thousand (4,760)(23,949) PDF p. 76
Comprehensive loss attributable to equity holdersUSD thousand (4,609)(23,035) PDF p. 76
Comprehensive profit or loss attributable to non-controlling interestsUSD thousand 5(1,527) PDF p. 76
Total comprehensive loss attributableUSD thousand (4,604)(24,562) PDF p. 76
Definitions & sources

Group Loss per Share

1 metrics

Units appear below each metric. Scroll to compare years

Group Loss per Share from Medtecs International Corporation Limited Annual Report 2025
Metric / unit 2025Group2024Group Source
Group Loss per Share
Basic and diluted loss per shareUS cents per share (0.874)(4.115) PDF p. 76
Definitions & sources

Group and Company Financial Position

30 metrics

Units appear below each metric. Scroll to compare years

Group and Company Financial Position from Medtecs International Corporation Limited Annual Report 2025
Metric / unit 2025Group2024Group2025Company2024Company Source
Group and Company Financial Position
Property plant and equipmentUSD thousand 51,61218,3252150 PDF p. 77
Investment propertyUSD thousand 2,2832,394–– PDF p. 77
Assets held for leasingUSD thousand 3,7513,667–– PDF p. 77
Right-of-use assetsUSD thousand 9,7234,458248374 PDF p. 77
Net investment in sub-leaseUSD thousand –4,7104,2714,710 PDF p. 77
Investment in subsidiariesUSD thousand ––50,74927,000 PDF p. 77
Intangible assetsUSD thousand 2,8393,116–– PDF p. 77
Deferred tax assetsUSD thousand 1,5812,284–– PDF p. 77
Other non-current assetsUSD thousand 1,35874510879 PDF p. 77
Total non-current assetsUSD thousand 73,14739,69955,39732,213 PDF p. 77
InventoriesUSD thousand 28,21525,544603390 PDF p. 77
Trade receivablesUSD thousand 19,25210,666117173 PDF p. 77
Other current assetsUSD thousand 5,76134,72224225,009 PDF p. 77
Cash bank balances and fixed depositsUSD thousand 19,36827,3361,444795 PDF p. 77
Total current assetsUSD thousand 72,59698,2682,40626,367 PDF p. 77
Total assetsUSD thousand 145,743137,96757,80358,580 PDF p. 77
Trade payables and other current liabilitiesUSD thousand 20,5716,200700609 PDF p. 77
Lease liabilities currentUSD thousand 819633148149 PDF p. 77
Due to subsidiaries netUSD thousand ––19,58913,361 PDF p. 77
Loans and borrowingsUSD thousand 17,53619,358–– PDF p. 77
Income tax payableUSD thousand 8082,113–5 PDF p. 77
Total current liabilitiesUSD thousand 39,73428,30420,43714,124 PDF p. 77
Net current assets or liabilitiesUSD thousand 32,86269,964(18,031)12,243 PDF p. 77
Lease liabilities non-currentUSD thousand 3,3362,294288367 PDF p. 77
Deferred tax liabilitiesUSD thousand 5015251812 PDF p. 77
Pension benefit obligationUSD thousand 1151789898 PDF p. 77
Other non-current liabilitiesUSD thousand 914–– PDF p. 77
Total non-current liabilitiesUSD thousand 3,9613,011404477 PDF p. 77
Total liabilitiesUSD thousand 43,69531,31520,84114,601 PDF p. 77
Net assetsUSD thousand 102,048106,65236,96243,979 PDF p. 77
Definitions & sources

Group and Company Equity

11 metrics

Units appear below each metric. Scroll to compare years

Group and Company Equity from Medtecs International Corporation Limited Annual Report 2025
Metric / unit 2025Group2024Group2025Company2024Company Source
Group and Company Equity
Share capitalUSD thousand 27,47127,47127,47127,471 PDF p. 78
Treasury shares deductedUSD thousand (2,361)(2,361)(2,361)(2,361) PDF p. 78
Share premiumUSD thousand 4,7214,7214,7214,721 PDF p. 78
Revenue reservesUSD thousand 72,43977,2046,45413,475 PDF p. 78
Remeasurement gain on retirement benefit obligationsUSD thousand 153249116112 PDF p. 78
Foreign currency translation reservesUSD thousand (1,257)(1,509)–– PDF p. 78
Other reservesUSD thousand 394394561561 PDF p. 78
Equity attributable to equity holdersUSD thousand 101,560106,16936,96243,979 PDF p. 78
Non-controlling interestsUSD thousand 488483–– PDF p. 78
Total equityUSD thousand 102,048106,65236,96243,979 PDF p. 78
Total equity and liabilitiesUSD thousand 145,743137,96757,80358,580 PDF p. 78
Definitions & sources

Group Changes in Equity 2025

7 metrics

Units appear below each metric. Scroll to compare years

Group Changes in Equity 2025 from Medtecs International Corporation Limited Annual Report 2025
Metric / unit 2025GroupShare capital2025GroupShare premium2025GroupRevenue reserves2025GroupRemeasurement gain on retirement benefit obligations2025GroupForeign currency translation reserves2025GroupOther reserves2025GroupTreasury shares2025GroupNon-controlling interests2025GroupTotal equity Source
Group Changes in Equity 2025
Opening balance at 1 January 2025USD thousand 27,4714,72177,204249(1,509)394(2,361)483106,652 PDF p. 79
Net loss for the yearUSD thousand ––(4,765)––––5(4,760) PDF p. 79
Foreign currency translation reservesUSD thousand ––––252–––252 PDF p. 79
Remeasurement loss on retirement benefit obligation net of taxUSD thousand –––(96)––––(96) PDF p. 79
Other comprehensive income or lossUSD thousand –––(96)252–––156 PDF p. 79
Total comprehensive income or lossUSD thousand ––(4,765)(96)252––5(4,604) PDF p. 79
Closing balance at 31 December 2025USD thousand 27,4714,72172,439153(1,257)394(2,361)488102,048 PDF p. 79
Definitions & sources

Group Changes in Equity 2024

9 metrics

Units appear below each metric. Scroll to compare years

Group Changes in Equity 2024 from Medtecs International Corporation Limited Annual Report 2025
Metric / unit 2024GroupShare capital2024GroupShare premium2024GroupRevenue reserves2024GroupRemeasurement gain on retirement benefit obligations2024GroupForeign currency translation reserves2024GroupOther reserves2024GroupTreasury shares2024GroupNon-controlling interests2024GroupTotal equity Source
Group Changes in Equity 2024
Opening balance at 1 January 2024USD thousand 27,4714,72199,618211(850)394(2,361)1,104130,308 PDF p. 80
Net loss for the yearUSD thousand ––(22,422)––––(1,527)(23,949) PDF p. 80
Foreign currency translation reservesUSD thousand ––––(659)–––(659) PDF p. 80
Remeasurement gain on retirement benefit obligation net of taxUSD thousand –––46––––46 PDF p. 80
Other comprehensive income or lossUSD thousand –––46(659)–––(613) PDF p. 80
Total comprehensive income or lossUSD thousand ––(22,422)46(659)––(1,527)(24,562) PDF p. 80
Reclassification of actuarial gains to revenue reservesUSD thousand ––8(8)––––– PDF p. 80
Deconsolidation of subsidiariesUSD thousand –––––––906906 PDF p. 80
Closing balance at 31 December 2024USD thousand 27,4714,72177,204249(1,509)394(2,361)483106,652 PDF p. 80
Definitions & sources

Company Changes in Equity 2024

5 metrics

Units appear below each metric. Scroll to compare years

Company Changes in Equity 2024 from Medtecs International Corporation Limited Annual Report 2025
Metric / unit 2024CompanyShare capital2024CompanyShare premium2024CompanyRevenue reserves2024CompanyRemeasurement gain on retirement benefit obligations2024CompanyOther reserves2024CompanyTreasury shares2024CompanyTotal equity Source
Company Changes in Equity 2024
Opening balance at 1 January 2024USD thousand 27,4714,72132,071105561(2,361)62,568 PDF p. 81
Net loss for the yearUSD thousand ––(18,596)–––(18,596) PDF p. 81
Remeasurement gain on retirement benefit obligation net of taxUSD thousand –––7––7 PDF p. 81
Total comprehensive income or lossUSD thousand ––(18,596)7––(18,589) PDF p. 81
Closing balance at 31 December 2024USD thousand 27,4714,72113,475112561(2,361)43,979 PDF p. 81
Definitions & sources

Company Changes in Equity 2025

5 metrics

Units appear below each metric. Scroll to compare years

Company Changes in Equity 2025 from Medtecs International Corporation Limited Annual Report 2025
Metric / unit 2025CompanyShare capital2025CompanyShare premium2025CompanyRevenue reserves2025CompanyRemeasurement gain on retirement benefit obligations2025CompanyOther reserves2025CompanyTreasury shares2025CompanyTotal equity Source
Company Changes in Equity 2025
Opening balance at 1 January 2025USD thousand 27,4714,72113,475112561(2,361)43,979 PDF p. 81
Net loss for the yearUSD thousand ––(7,021)–––(7,021) PDF p. 81
Remeasurement gain on retirement benefit obligation net of taxUSD thousand –––4––4 PDF p. 81
Total comprehensive income or lossUSD thousand ––(7,021)4––(7,017) PDF p. 81
Closing balance at 31 December 2025USD thousand 27,4714,7216,454116561(2,361)36,962 PDF p. 81
Definitions & sources

Group Cash Flows from Operating Activities

33 metrics

Units appear below each metric. Scroll to compare years

Group Cash Flows from Operating Activities from Medtecs International Corporation Limited Annual Report 2025
Metric / unit 2025Group2024Group Source
Group Cash Flows from Operating Activities
Loss before taxUSD thousand (5,144)(23,440) PDF p. 82
Depreciation of property plant and equipmentUSD thousand 3,4664,276 PDF p. 82
Depreciation of assets held for leasingUSD thousand 2,0161,860 PDF p. 82
Depreciation of right-of-use assetsUSD thousand 7881,028 PDF p. 82
Depreciation of investment propertyUSD thousand 111111 PDF p. 82
Amortisation of computer softwareUSD thousand 280277 PDF p. 82
Impairment loss on property plant and equipmentUSD thousand –138 PDF p. 82
Allowance for inventory write-downUSD thousand 6757,356 PDF p. 82
Allowance for expected credit losses on trade receivablesUSD thousand 5019,817 PDF p. 82
Allowance for expected credit losses on other receivablesUSD thousand 2,5692,257 PDF p. 82
Reversal of inventory write-downUSD thousand (1,911)(103) PDF p. 82
Reversal of expected credit losses on trade receivablesUSD thousand (567)(3) PDF p. 82
Reversal of impairment loss on other current assetsUSD thousand (50)– PDF p. 82
Write-off of inventoriesUSD thousand 315– PDF p. 82
Gain on deconsolidationUSD thousand –(2,199) PDF p. 82
Loss on derecognition of net investment in lease receivableUSD thousand 485– PDF p. 82
Interest expense on loans and lease liabilitiesUSD thousand 771764 PDF p. 82
Other finance expensesUSD thousand 4030 PDF p. 82
Unrealised currency translation gainsUSD thousand (9)(20) PDF p. 82
Net changes in pension benefits obligationUSD thousand (156)(674) PDF p. 82
Interest incomeUSD thousand (915)(1,457) PDF p. 82
Gain on disposal of property plant and equipmentUSD thousand (7)(35) PDF p. 82
Operating cash flows before working capital changesUSD thousand 3,258(17) PDF p. 82
InventoriesUSD thousand 2,847296 PDF p. 82
Trade receivablesUSD thousand (5,023)2,226 PDF p. 82
Other current assetsUSD thousand 1,525(28,311) PDF p. 82
Guarantee deposits and deposits non-currentUSD thousand (70)879 PDF p. 82
Trade payables and other liabilitiesUSD thousand (4,647)27,851 PDF p. 82
Deferred lease incomeUSD thousand (5)(4) PDF p. 82
Cash generated from operationsUSD thousand (2,115)2,920 PDF p. 82
Income taxes paidUSD thousand (242)(547) PDF p. 82
Other finance cost paidUSD thousand (40)(30) PDF p. 82
Net cash used in or from operating activitiesUSD thousand (2,397)2,343 PDF p. 82
Definitions & sources

Group Cash Flows from Investing Activities

12 metrics

Units appear below each metric. Scroll to compare years

Group Cash Flows from Investing Activities from Medtecs International Corporation Limited Annual Report 2025
Metric / unit 2025Group2024Group Source
Group Cash Flows from Investing Activities
Proceeds from disposal of property plant and equipmentUSD thousand 748 PDF p. 83
Proceeds from disposal of assets held for leasingUSD thousand 2428 PDF p. 83
Purchases of property plant and equipmentUSD thousand (4,523)(1,683) PDF p. 83
Purchases of assets held for leasingUSD thousand (2,124)(1,640) PDF p. 83
Purchases of intangible assetsUSD thousand (3)(30) PDF p. 83
Interest received from fixed deposit unquoted bond and finance leaseUSD thousand 9151,457 PDF p. 83
Fixed deposits with maturity more than 90 daysUSD thousand 4,050(855) PDF p. 83
Net cash inflow from acquisition of subsidiariesUSD thousand 757– PDF p. 83
Acquisition of financial assets at FVOCIUSD thousand (430)– PDF p. 83
Proceeds from redemption of unquoted bondUSD thousand 3,000– PDF p. 83
Net cash outflow from deconsolidation of subsidiariesUSD thousand –(50) PDF p. 83
Net cash from or used in investing activitiesUSD thousand 1,673(2,725) PDF p. 83
Definitions & sources

Group Cash Flows from Financing Activities

7 metrics

Units appear below each metric. Scroll to compare years

Group Cash Flows from Financing Activities from Medtecs International Corporation Limited Annual Report 2025
Metric / unit 2025Group2024Group Source
Group Cash Flows from Financing Activities
Uplift of fixed depositsUSD thousand 2,6321,043 PDF p. 83
Proceeds from loans and borrowingsUSD thousand 17,53619,358 PDF p. 83
Repayment of loans and borrowingsUSD thousand (19,358)(23,861) PDF p. 83
Interest paid on loans and borrowingsUSD thousand (443)(503) PDF p. 83
Principal payments of lease liabilitiesUSD thousand (553)(715) PDF p. 83
Interest payments of lease liabilitiesUSD thousand (328)(261) PDF p. 83
Net cash used in financing activitiesUSD thousand (514)(4,939) PDF p. 83
Definitions & sources

Group Cash and Cash Equivalents Reconciliation

4 metrics

Units appear below each metric. Scroll to compare years

Group Cash and Cash Equivalents Reconciliation from Medtecs International Corporation Limited Annual Report 2025
Metric / unit 2025Group2024Group Source
Group Cash and Cash Equivalents Reconciliation
Net decrease in cash and cash equivalentsUSD thousand (1,238)(5,321) PDF p. 83
Cash and cash equivalents at beginning of yearUSD thousand 16,78922,305 PDF p. 83
Effects of currency translationUSD thousand (48)(195) PDF p. 83
Cash and cash equivalents at end of yearUSD thousand 15,50316,789 PDF p. 83
Definitions & sources

Group and Company Cash and Cash Equivalents Note23

6 metrics

Units appear below each metric. Scroll to compare years

Group and Company Cash and Cash Equivalents Note23 from Medtecs International Corporation Limited Annual Report 2025
Metric / unit 2025Group2024Group2025Company2024Company Source
Group and Company Cash and Cash Equivalents Note23
Cash in handUSD thousand 454111 PDF p. 131
Cash at banksUSD thousand 15,4589,7301,396747 PDF p. 131
Fixed depositsUSD thousand 3,86517,5654747 PDF p. 131
Cash bank balances and fixed deposits totalUSD thousand 19,36827,3361,444795 PDF p. 131
Fixed deposits over 90 days and less than one year including pledged deposits excludedUSD thousand (3,865)(10,547)(47)(47) PDF p. 131
Cash and cash equivalentsUSD thousand 15,50316,7891,397748 PDF p. 131
Definitions & sources

Four-year Historical Charts

8 metrics

Units appear below each metric. Scroll to compare years

Four-year Historical Charts from Medtecs International Corporation Limited Annual Report 2025
Metric / unit 2025Group2024Group2023Group2022Group Source
Four-year Historical Charts
Revenue totalUSD million 78.954.452.656.2 PDF p. 13
Revenue first halfUSD million 36.425.526.531.6 PDF p. 13
Revenue second halfUSD million 42.528.926.124.6 PDF p. 13
Gross profitUSD million 12.66.96.0-3.3 PDF p. 14
Net profit or lossUSD million -4.8-23.9-22.5-29.3 PDF p. 14
Gross profit margin% 16.012.811.2-5.8 PDF p. 14
Net profit margin% -6.1-43.9-42.8-51.9 PDF p. 14
Capital expenditureUSD million 4.51.73.118.1 PDF p. 14
Definitions & sources

Where the money comes from

Segment information

By business

Business segments 2025 (Group, US$'000) 12 lines
Business segments 2025 (Group, US$'000)
Item / unit 2025Manufacturing2025Hospital services2025Distribution and others2025Group Source
Revenue
Third partiesUS$'000 58,96917,8422,15578,966 PDF p. 137
Intersegment salesUS$'000 25,313––25,313 PDF p. 137
Total revenueUS$'000 84,28217,8422,155104,279 PDF p. 137
EliminationsUS$'000 (25,313)––(25,313) PDF p. 137
Results
ResultsUS$'000 (7,731)2,832(349)(5,248) PDF p. 137
Assets
Total assetsUS$'000 127,74614,0173,980145,743 PDF p. 137
Liabilities
Total liabilitiesUS$'000 43,289403343,695 PDF p. 137
Other segment information
Capital expenditureUS$'000 5,0651,205–6,270 PDF p. 137
Depreciation and amortisationUS$'000 4,0612,4891116,661 PDF p. 137
Allowance for write down of inventoryUS$'000 516–159675 PDF p. 137
Allowance for ECL on receivablesUS$'000 3,070––3,070 PDF p. 137
Other non-cash expenses - netUS$'000 628––628 PDF p. 137
Notes

Years ended 31 December 2025. Segment results, assets and liabilities include items directly attributable to a segment as well as those allocated on a reasonable basis. Segment revenue, expenses and results include transfers between business segments, eliminated on consolidation. Financial expenses, financial income, tax credit and net loss are shown in the Group column only. An unlabelled subtotal row (58,969 17,842 2,155 78,966) after Eliminations is not extracted.

Business segments 2024 (Group, US$'000) 14 lines
Business segments 2024 (Group, US$'000)
Item / unit 2024Manufacturing2024Hospital services2024Distribution and others2024Group Source
Revenue
Third partiesUS$'000 36,47715,1742,77254,423 PDF p. 138
Intersegment salesUS$'000 24,685––24,685 PDF p. 138
Total revenueUS$'000 61,16215,1742,77279,108 PDF p. 138
EliminationsUS$'000 (24,685)––(24,685) PDF p. 138
Results
ResultsUS$'000 (25,366)1,720(457)(24,103) PDF p. 138
Assets
Total assetsUS$'000 121,13411,9914,842137,967 PDF p. 138
Liabilities
Total liabilitiesUS$'000 30,9643411031,315 PDF p. 138
Other segment information
Capital expenditureUS$'000 1,1992,154–3,353 PDF p. 138
Depreciation and amortisationUS$'000 4,9992,4421117,552 PDF p. 138
Allowance for inventory lossesUS$'000 7,280–767,356 PDF p. 138
Allowance for ECL on receivablesUS$'000 12,074––12,074 PDF p. 138
Gain on deconsolidation of subsidiariesUS$'000 (2,199)––(2,199) PDF p. 138
Allowance for impairment loss on property, plant and equipmentUS$'000 138––138 PDF p. 138
Other non-cash expenses - netUS$'000 (757)––(757) PDF p. 138
Notes

Years ended 31 December 2024 (comparative). Financial expenses, financial income, tax expense and net loss are shown in the Group column only. An unlabelled subtotal row (36,477 15,174 2,772 54,423) after Eliminations is not extracted.

By geography

Geographical information (US$'000) 10 lines
Geographical information (US$'000)
Item / unit 2025Sales to external customers2024Sales to external customers2025Non-current assets2024Non-current assets Source
Geographical information
SingaporeUS$'000 ––53 PDF p. 139
PhilippinesUS$'000 3,4213,4838,7359,579 PDF p. 139
CambodiaUS$'000 1,760–43,58615,635 PDF p. 139
TaiwanUS$'000 23,78216,34613,58711,482 PDF p. 139
ChinaUS$'000 ––1,023935 PDF p. 139
BermudaUS$'000 ––4,199– PDF p. 139
LuxembourgUS$'000 19,93918,650–– PDF p. 139
United State of AmericaUS$'000 22,3777,699–– PDF p. 139
United KingdomUS$'000 6,7496,153–– PDF p. 139
OthersUS$'000 9382,092–– PDF p. 139
Notes

Significant revenue and non-current assets information based on the geographical location of customers and assets respectively. Geographical segments are based on the location of the Group's assets; sales to external customers are based on the location of customers. The unlabelled total row (78,966 54,423 71,135 37,634) is not extracted as a row.

Debt

Borrowings

Borrowing notes 2 tables

Loans and borrowings (Note 25)

Loans and borrowings (Note 25)
Item / unit 2025Group weighted average effective interest rate (% per annum)2025Group maturity2025Group carrying amount2024Group carrying amount Source
New Taiwan Dollar (NTD) loans
- UnsecuredUS$'000 (rate in %) 1.7820261,5942,137 PDF p. 132
- SecuredUS$'000 (rate in %) 2.29202615,94217,221 PDF p. 132
Notes

Property, plant and equipment and fixed deposits with carrying amounts of $4,713,000 and $1,705,000, respectively (2024: $4,580,000 and $4,337,000, respectively) (Notes 12 and 23) are used to secure the loans and borrowings of the Group amounting to $15,942,000 (2024: $17,221,000).

The loans and borrowings pertain to withdrawn amount from the revolving credit line of the Group, which are short-term in nature, have payment terms from 2 to 6 months and can be renewed upon maturity.

All borrowings are NTD-denominated and current; floating rate per Note 31.

Lease liabilities on statements of financial position

Lease liabilities on statements of financial position
Item / unit 2025Group2024Group2025Company2024Company Source
Current liabilities
Lease liabilitiesUS$'000 819633148149 PDF p. 77
Non-current liabilities
Lease liabilitiesUS$'000 3,3362,294288367 PDF p. 77
Current liabilities
Loans and borrowingsUS$'000 17,53619,358–– PDF p. 77

Payout

Dividends & distributions

Dividend policy

ItemValuePeriod / scopeSource
Dividend policy The Company does not have a fixed policy on the declaration of dividends. The form, frequency and amount of future dividends declared will depend on earnings, general financial position, results of operation, capital requirements, cash flow, general business condition, or development plans and other factors as the Directors may, in their absolute discretion, deem appropriate. Company PDF p. 52

Dividends declared and proposed

ItemValuePeriod / scopeSource
FY2025 dividend recommendation the Board is not recommending any dividend distribution to its shareholders for FY2025 FY2025 PDF p. 52

Extracted from Medtecs International Corporation Limited Annual Report 2025 and checked against the cited pages; see the original report for full context.

Auditor’s report

Audit & risk signals

Audit opinion

ItemValuePeriod / scopeSource
Auditor Baker Tilly TFW LLP Group and Company PDF p. 75
Engagement partner Ong Kian Guan Group and Company PDF p. 75
Auditor's report date 11 April 2026 Group and Company · As at 2026-04-11 PDF p. 75
Opinion properly drawn up in accordance with the Singapore Financial Reporting Standards (International) (“SFRS(I)”) so as to give a true and fair view Group and Company, year ended 31 December 2025 PDF p. 71

Key audit matters

ItemValuePeriod / scopeSource
Assessment of inventory valuation Significant judgment and estimates are involved in the allocations of direct labour and factory overheads and the assessment of inventory allowance which may have significant impact on the valuation of inventories. Group, as at 31 December 2025 PDF p. 72

Extracted from Medtecs International Corporation Limited Annual Report 2025 and checked against the cited pages; see the original report for full context.

How to read these figures

Group and parent company or bank figures are labelled separately. Parentheses indicate negative amounts; a dash and NA retain the report’s notation.

Comparative figures follow Medtecs International Corporation Limited Annual Report 2025, including retrospective adjustments. Adjusted and reported earnings may have different definitions; refer to each statement’s notes.

Audited statements are USD thousands, except basic and diluted loss per share in US cents. The Group reports consolidated statements; the Company separately reports financial position and changes in equity.

The Group reported operating cash outflow in FY2025 and operating cash inflow in FY2024. Cash-flow closing cash differs from financial-position cash/bank balances/fixed deposits; Note23 excludes fixed deposits over 90 days and less than one year including pledged fixed deposits: USD3.865m in FY2025 and USD10.547m in FY2024. The note reconciles exactly to both statements.

Treasury shares and losses remain negative. Non-controlling interests show a small profit in FY2025 although the Group incurred a net loss. FY2024 equity includes actuarial gain reclassification and subsidiary deconsolidation.

The FY2025 report provides historical charts for FY2022–FY2025, not a five-year summary. These four years are retained without fabricating FY2021. Chart legend identifies gross profit separately from net profit/loss and first-half revenue separately from second-half revenue.

Original chart and narrative figures are retained despite four discrepancies against audited figures: FY2025 revenue 78.9m versus audited 78.966m (rounds to79.0m); FY2024 gross margin 12.8% versus audited 12.6%; FY2025 net margin −6.1% versus audited −6.0%; FY2024 net margin −43.9% versus audited −44.0%. These are report presentation differences, not adjustments to audited statements.

The financial-review table labels USD19.4m/27.3m as cash and cash equivalents, but these correspond to financial-position cash/bank/fixed deposits. The audited cash-flow equivalent balances are USD15.503m/16.789m after Note23 exclusions and remain separately shown.

These tables show the available extracted figures. The original annual report contains the full statements, notes and definitions.